Updates on the Pathogenesis of Advanced Lung Cancer-induced Cachexia

Overview

Journal Thorac Cancer

Specialties Oncology
Pulmonary Medicine

Date 2018 Nov 22

PMID 30461213

Citations 22

Authors

Ruifang Zhu

Zhihong Liu

Ran Jiao

Chichen Zhang

Qi Yu

Shifan Han

Zhiguang Duan

Affiliations

Soon will be listed here.

Abstract

Advanced lung cancer is becoming a chronic disease threatening human life and health. Cachexia has been recognized as the most common problem associated with advanced lung cancer. Lung cancer-induced cachexia seriously affects patients' quality of life. The present article summarizes the pathogenesis of advanced lung cancer-induced cachexia from three aspects: anorexia, cytokines, and energy and metabolic abnormalities. In addition, the present article proposes corresponding nursing measures based on cachexia pathogenesis to improve the quality of life and survival rate of cachectic patients with advanced lung cancer by combining continuously advancing treatment regimens and effective nursing. The present article also provides references for healthcare professionals when administering related treatments and nursing care.

Citing Articles

Non-cancerous CT findings as predictors of survival outcome in advanced non-small cell lung cancer patients treated with first-generation EGFR-TKIs.

Prakaikietikul P, Tajarenmuang P, Losuriya P, Ina N, Ketpueak T, Kanthawang T PLoS One. 2025; 20(2):e0313577.

PMID: 39908320 PMC: 11798445. DOI: 10.1371/journal.pone.0313577.

Correlation between changes in nutritional status and tumor response in patients receiving immunotherapy for lung cancer (NUTIMMUNO study).

Mahe M, Seegers V, Vansteene D Support Care Cancer. 2024; 32(5):312.

PMID: 38676729 DOI: 10.1007/s00520-024-08519-x.

Perception of subjective lived experiences of individuals with anorexia-cachexia in patients with advanced lung cancer.

Yennurajalingam S, Mott F, Lu Z, Urbauer D, Stanton P, Torres H Asia Pac J Oncol Nurs. 2024; 10(Suppl 1):100314.

PMID: 38197040 PMC: 10772162. DOI: 10.1016/j.apjon.2023.100314.

The Naples Prognostic Score Is a Useful Tool to Assess Surgical Treatment in Non-Small Cell Lung Cancer.

Elia S, Patirelis A, Hardavella G, Santone A, Carlea F, Pompeo E Diagnostics (Basel). 2023; 13(24).

PMID: 38132225 PMC: 10742842. DOI: 10.3390/diagnostics13243641.

Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients-A Retrospective Observational Study.

Siringo M, Gentile G, Caponnetto S, Sperduti I, Santini D, Cortesi E Cancers (Basel). 2023; 15(13).

PMID: 37444532 PMC: 10340506. DOI: 10.3390/cancers15133422.

References

Eley H, Tisdale M . Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. J Biol Chem. 2007; 282(10):7087-97. DOI: 10.1074/jbc.M610378200. View

Argiles J, Lopez-Soriano F, Busquets S . Mechanisms and treatment of cancer cachexia. Nutr Metab Cardiovasc Dis. 2012; 23 Suppl 1:S19-24. DOI: 10.1016/j.numecd.2012.04.011. View

Lee Y, Baek J, Jung S, Kwak J, Kim J, Shin J . Ultrasound-guided fine needle aspiration of thyroid nodules: a consensus statement by the korean society of thyroid radiology. Korean J Radiol. 2015; 16(2):391-401. PMC: 4347275. DOI: 10.3348/kjr.2015.16.2.391. View

Peterson J, Feeback K, Baas J, Pizza F . Tumor necrosis factor-alpha promotes the accumulation of neutrophils and macrophages in skeletal muscle. J Appl Physiol (1985). 2006; 101(5):1394-9. DOI: 10.1152/japplphysiol.01453.2005. View

Argiles J, Busquets S, Toledo M, Lopez-Soriano F . The role of cytokines in cancer cachexia. Curr Opin Support Palliat Care. 2009; 3(4):263-8. DOI: 10.1097/SPC.0b013e3283311d09. View

Mantovani G, Maccio A, Mura L, Massa E, Mudu M, Mulas C . Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J Mol Med (Berl). 2001; 78(10):554-61. DOI: 10.1007/s001090000137. View

Hasselgren P, Wray C, Mammen J . Molecular regulation of muscle cachexia: it may be more than the proteasome. Biochem Biophys Res Commun. 2002; 290(1):1-10. DOI: 10.1006/bbrc.2001.5849. View

Pelicano H, Martin D, Xu R, Huang P . Glycolysis inhibition for anticancer treatment. Oncogene. 2006; 25(34):4633-46. DOI: 10.1038/sj.onc.1209597. View

Fredrix E, Soeters P, Wouters E, Deerenberg I, Von Meyenfeldt M, Saris W . Effect of different tumor types on resting energy expenditure. Cancer Res. 1991; 51(22):6138-41. View

10.

Argiles J, Busquets S, Felipe A, Lopez-Soriano F . Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol. 2005; 37(5):1084-104. DOI: 10.1016/j.biocel.2004.10.003. View

11.

Straub R, Cutolo M, Buttgereit F, Pongratz G . Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med. 2010; 267(6):543-60. DOI: 10.1111/j.1365-2796.2010.02218.x. View

12.

Jafri S, Previgliano C, Khandelwal K, Shi R . Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients. Clin Med Insights Oncol. 2015; 9:87-93. PMC: 4640427. DOI: 10.4137/CMO.S30891. View

13.

Ryden M, Arvidsson E, Blomqvist L, Perbeck L, Dicker A, Arner P . Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem Biophys Res Commun. 2004; 318(1):168-75. DOI: 10.1016/j.bbrc.2004.04.010. View

14.

Preston T, Slater C, McMillan D, FALCONER J, Shenkin A, Fearon K . Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr. 1998; 128(8):1355-60. DOI: 10.1093/jn/128.8.1355. View

15.

Fearon K, Strasser F, Anker S, Bosaeus I, Bruera E, Fainsinger R . Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489-95. DOI: 10.1016/S1470-2045(10)70218-7. View

16.

Tranmer J, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K . Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage. 2003; 25(5):420-9. DOI: 10.1016/s0885-3924(03)00074-5. View

17.

Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T . Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer. 2014; 23(6):1699-708. DOI: 10.1007/s00520-014-2534-3. View

18.

Op den Kamp C, Langen R, Snepvangers F, Theije C, Schellekens J, Laugs F . Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. Am J Clin Nutr. 2013; 98(3):738-48. DOI: 10.3945/ajcn.113.058388. View

19.

Guttridge D, Mayo M, Madrid L, Wang C, Baldwin Jr A . NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000; 289(5488):2363-6. DOI: 10.1126/science.289.5488.2363. View

20.

Antunes D, Padrao A, Maciel E, Santinha D, Oliveira P, Vitorino R . Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting. Biochim Biophys Acta. 2014; 1841(6):896-905. DOI: 10.1016/j.bbalip.2014.03.004. View